Clinical Trial Update: A Study of GB261 in Systemic Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluating GB261 for systemic sclerosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• GB261

Snippet

Sponsor: Ruijin Hospital | Conditions: Systemic Sclerosis (SSc) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING